Resistance to Androgen-Pathway Drugs in Prostate Cancer REPLY

被引:27
作者
Antonarakis, Emmanuel S. [1 ]
Nakazawa, Mary [1 ]
Luo, Jun [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
关键词
D O I
10.1056/NEJMc1412594
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2234 / 2234
页数:1
相关论文
共 3 条
  • [1] Personalizing treatment in patients with castrate-resistant prostate cancer: A study of predictive factors for secondary endocrine therapies activity
    Loriot, Yohann
    Massard, Christophe
    Albiges, Laurence
    Di Palma, Mario
    Blanchard, Pierre
    Bossi, Alberto
    Chauchereau, Anne
    Escudier, Bernard J.
    Fizazi, Karim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [2] RNA SEQUENCING OF CIRCULATING TUMOR CELLS FROM MEN WITH CASTRATION-RESISTANT PROSTATE CANCER
    Nakazawa, Mary
    Lu, Changxue
    Chen, Yan
    Antonarakis, Emmanuel
    Luo, Jun
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04) : E583 - E583
  • [3] Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
    Zhao, XY
    Malloy, PJ
    Krishnan, AV
    Swami, S
    Navone, NM
    Peehl, DM
    Feldman, D
    [J]. NATURE MEDICINE, 2000, 6 (06) : 703 - 706